ArticleClinical endoscopy2026
Touch imprint cytology for rapid on-site evaluation in endoscopic ultrasound-guided tissue acquisition of pancreatic tumors: diagnostic performance and practical value-a single-center retrospective observational study from Japan.
Article in Clinical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Touch imprint cytology: a practical step toward standardized rapid on-site evaluation.Clinical endoscopy · 2026Article
Corrections and comments
- Commented on by
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmong various specimen preparation techniques for rapid on-site evaluation (ROSE), touch imprint cytology (TIC) is widely used; however, its utility for pancreatic lesions has not been fully validated. This study aimed to evaluate the diagnostic performance of TIC-based ROSE during endoscopic ultrasound-guided tissue acquisition (EUS-TA) for pancreatic lesions.
methodsThis retrospective study included 385 patients who underwent EUS-TA for pancreatic lesions at a single center. ROSE using TIC was performed in 370 cases (96.1%). Diagnostic concordance between TIC-based ROSE and histology, as well as diagnostic accuracy relative to the final diagnosis, were assessed. The diagnostic performance of TIC was compared with that of spray cytology (SC) and instrument rinse cytology (IRC). Multivariate analysis was conducted to identify factors associated with discordance between TIC-based ROSE and histology.
resultsThe concordance rate between TIC-based ROSE and histology was 85.1% (κ=0.575). For the final diagnosis, TIC-based ROSE demonstrated a sensitivity of 92.3%, specificity of 96.9%, and accuracy of 92.7%, showing superior diagnostic performance within the same workflow compared with SC and IRC. Smaller lesion size and the use of a 25-gauge needle were identified as independent factors for discordance.
conclusionsTIC is a reliable ROSE technique in EUS-TA for pancreatic lesions, providing high diagnostic accuracy and a low inadequacy rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.